METHOD FOR PREVENTING OSTEOPOROSIS IN MALE PATIENTS DISTINGUISHED BY PARTIAL ANDROGEN AGE-SPECIFIC DEFICIENCY (PADAM)

FIELD: medicine. ^ SUBSTANCE: method involves reducing blood plasma level of parathyroid hormone, insulin-like growth factor-1, 1,25(OH)2D3, alkaline phosphatase, calcium, thyroid-stimulating hormone, T4, adrenocorticotropic hormone, hydrocortisone, increasing blood plasma level of calcitonin and ph...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	MAZUROV V.I, KARPISHCHENKO A.I, PECHERSKIJ A.V, SEMIGLAZOV V.F
Format:	Patent
Sprache:	eng ; rus
Schlagworte:	DIAGNOSIS HUMAN NECESSITIES HYGIENE IDENTIFICATION MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SURGERY
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	FIELD: medicine. ^ SUBSTANCE: method involves reducing blood plasma level of parathyroid hormone, insulin-like growth factor-1, 1,25(OH)2D3, alkaline phosphatase, calcium, thyroid-stimulating hormone, T4, adrenocorticotropic hormone, hydrocortisone, increasing blood plasma level of calcitonin and phosphate. Pulsating secretion mode of thyroid-stimulating hormone, T4, adrenocorticotropic hormone and hydrocortisone is recovered by individual selection of testosterone preparation dose providing normalized level of lutropin, general testosterone, free testosterone, globulin binding sex hormones, free androgen index, 5alpha-dihydrotestosterone, 17beta-estradiol, recovery of pulsating lutropin and general testosterone secretion. ^ EFFECT: enhanced effectiveness in acting upon pathogenic aspects of osteoporosis prophylaxis.